论文部分内容阅读
目的:探讨康复新液对难治性消化性溃疡的临床治疗效果。方法:随机选取本院2014年1月-2015年2月收治的120例难治性消化性溃疡患者作为研究对象,随机分为观察组和对照组,对照组采用奥美拉唑肠溶胶囊联合阿莫西林胶囊治疗,观察组在对照组基础上加用康复新液,分析对比两组患者的临床治疗效果。结果:观察组总有效率为96.6%,与对照组的80.0%比较(P<0.05);观察组患者复发率6.6%低于对照组患者复发率25.0%(P<0.05)。结论:康复新液对难治性消化性溃疡的临床治疗效果明显。
Objective: To investigate the clinical effects of Kangfuxin solution on refractory peptic ulcer. Methods: A total of 120 patients with refractory peptic ulcer admitted from January 2014 to February 2015 in our hospital were selected randomly and divided into observation group and control group randomly. The control group was treated with omeprazole enteric-coated capsule Amoxicillin capsule treatment, the observation group on the basis of the control group with rehabilitation of new liquid, analysis and comparison of two groups of patients with clinical treatment. Results: The total effective rate in the observation group was 96.6%, compared with 80.0% in the control group (P <0.05). The recurrence rate in the observation group was 6.6% lower than that in the control group (25.0%, P <0.05). Conclusion: Kangfuxin solution is effective in the treatment of refractory peptic ulcer.